Status:
COMPLETED
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Glaucoma, Open-Angle
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will evaluate the safety and efficacy of Triple Combination Therapy compared with Fixed Combination brimonidine tartrate/timolol ophthalmic solution in patients with primary open-angle glau...
Eligibility Criteria
Inclusion
- Ocular hypertension or primary open-angle glaucoma in each eye
- Requires treatment with IOP-lowering medication in both eyes
Exclusion
- Required chronic use of ocular medications during the study other than study medication
- Use of any corticosteroids within 30 days
- History of any prior eye surgery, except for uncomplicated eye surgery performed more than 6 months before the Screening visit
- Anticipated wearing of contact lenses during the study
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT01241240
Start Date
March 1 2011
End Date
September 1 2013
Last Update
September 10 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bogotá, Colombia
2
Mexico City, Mexico